These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28537265)

  • 1. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.
    O'Neill PM; Amewu RK; Charman SA; Sabbani S; Gnädig NF; Straimer J; Fidock DA; Shore ER; Roberts NL; Wong MH; Hong WD; Pidathala C; Riley C; Murphy B; Aljayyoussi G; Gamo FJ; Sanz L; Rodrigues J; Cortes CG; Herreros E; Angulo-Barturén I; Jiménez-Díaz MB; Bazaga SF; Martínez-Martínez MS; Campo B; Sharma R; Ryan E; Shackleford DM; Campbell S; Smith DA; Wirjanata G; Noviyanti R; Price RN; Marfurt J; Palmer MJ; Copple IM; Mercer AE; Ruecker A; Delves MJ; Sinden RE; Siegl P; Davies J; Rochford R; Kocken CHM; Zeeman AM; Nixon GL; Biagini GA; Ward SA
    Nat Commun; 2017 May; 8():15159. PubMed ID: 28537265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana.
    Vanhove M; Schwabl P; Clementson C; Early AM; Laws M; Anthony F; Florimond C; Mathieu L; James K; Knox C; Singh N; Buckee CO; Musset L; Cox H; Niles-Robin R; Neafsey DE
    PLoS Pathog; 2024 Jun; 20(6):e1012013. PubMed ID: 38870266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.
    Agaba BB; Travis J; Smith D; Rugera SP; Zalwango MG; Opigo J; Katureebe C; Mpirirwe R; Bakary D; Antonio M; Khalid B; Ngonzi J; Kamya MR; Kaleebu P; Piot P; Cheng Q
    Malar J; 2024 Nov; 23(1):330. PubMed ID: 39501325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-resistant malaria.
    White NJ; Chotivanich K
    Clin Microbiol Rev; 2024 Dec; 37(4):e0010924. PubMed ID: 39404268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of
    Ogwang R; Osoti V; Wamae K; Ndwiga L; Muteru K; Ningwa A; Tuju J; Kinyanjui S; Osier F; Marsh K; Bejon P; Idro R; Ochola-Oyier LI
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0157623. PubMed ID: 39136465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana.
    Aniweh Y; Soulama A; Chirawurah J; Ansah F; Danwonno HA; Sogore F; Rouillier M; Campo B; Amenga-Etego L; Djimde AA; Awandare GA; Dembele L
    Microbiol Spectr; 2023 Jun; 11(3):e0491622. PubMed ID: 37093000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
    Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background.
    Nayak S; Peto TJ; Kucharski M; Tripura R; Callery JJ; Quang Huy DT; Gendrot M; Lek D; Nghia HDT; van der Pluijm RW; Dong N; Long LT; Vongpromek R; Rekol H; Hoang Chau N; Miotto O; Mukaka M; Dhorda M; von Seidlein L; Imwong M; Roca X; Day NPJ; White NJ; Dondorp AM; Bozdech Z
    Nat Commun; 2024 Dec; 15(1):10625. PubMed ID: 39639029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
    Rathmes G; Rumisha SF; Lucas TCD; Twohig KA; Python A; Nguyen M; Nandi AK; Keddie SH; Collins EL; Rozier JA; Gibson HS; Chestnutt EG; Battle KE; Humphreys GS; Amratia P; Arambepola R; Bertozzi-Villa A; Hancock P; Millar JJ; Symons TL; Bhatt S; Cameron E; Guerin PJ; Gething PW; Weiss DJ
    Malar J; 2020 Oct; 19(1):374. PubMed ID: 33081784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient Limitation Magnifies Fitness Costs of Antimalarial Drug Resistance Mutations.
    Nair S; Li X; Arya GA; McDew-White M; Ferrari M; Anderson T
    Antimicrob Agents Chemother; 2022 May; 66(5):e0152921. PubMed ID: 35465723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study.
    Watson OJ; Gao B; Nguyen TD; Tran TN; Penny MA; Smith DL; Okell L; Aguas R; Boni MF
    Lancet Microbe; 2022 Sep; 3(9):e701-e710. PubMed ID: 35931099
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Chahine ZM; Gupta M; Lenz T; Hollin T; Abel S; Banks C; Saraf A; Prudhomme J; Bhanvadia S; Florens LA; Le Roch KG
    Elife; 2024 Dec; 12():. PubMed ID: 39636094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H.
    Pacheco MA; Schneider KA; Cheng Q; Munde EO; Ndege C; Onyango C; Raballah E; Anyona SB; Ouma C; Perkins DJ; Escalante AA
    Malar J; 2020 Oct; 19(1):378. PubMed ID: 33092587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.
    Roh ME; Gutman J; Murphy M; Hill J; Madanitsa M; Kakuru A; Barsosio HC; Kariuki S; Lusingu JPA; Mosha F; Kajubi R; Kamya MR; Mathanga D; Chinkhumba J; Laufer MK; Mlugu E; Kamuhabwa AAR; Aklillu E; Minzi O; Okoro RN; Geidam AD; Ohieku JD; Desai M; Jagannathan P; Dorsey G; Ter Kuile FO
    medRxiv; 2024 Nov; ():. PubMed ID: 39649586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ResMAP-a saturation mutagenesis platform enabling parallel profiling of target-specific resistance-conferring mutations in
    Wall RJ; MacGowan SA; Hallyburton I; Syed AJ; Ajay Castro S; Dey G; Milne R; Patterson S; Phelan J; Wiedemar N; Wyllie S
    mBio; 2024 Oct; 15(10):e0170824. PubMed ID: 39191404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal and spatial dynamics of
    Vanhove M; Schwabl P; Clementson C; Early AM; Laws M; Anthony F; Florimond C; Mathieu L; James K; Knox C; Singh N; Buckee CO; Musset L; Cox H; Niles-Robin R; Neafsey DE
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352461
    [No Abstract]   [Full Text] [Related]  

  • 17. The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh
    Okitwi M; Shoue DA; Checkley LA; Orena S; Ceja FG; Taremwa Y; Tumwebaze PK; Katairo T; Byaruhanga O; Sievert MA; Garg S; Kreutzfeld OK; Legac J; Bailey JA; Nsobya SL; Conrad MD; Rosenthal PJ; Ferdig MT; Cooper RA
    Antimicrob Agents Chemother; 2024 Dec; 68(12):e0118324. PubMed ID: 39545737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali.
    Diakité SAS; Traoré K; Sanogo I; Clark TG; Campino S; Sangaré M; Dabitao D; Dara A; Konaté DS; Doucouré F; Cissé A; Keita B; Doumbouya M; Guindo MA; Toure MB; Sogoba N; Doumbia S; Awandare GA; Diakité M
    Malar J; 2019 Nov; 18(1):361. PubMed ID: 31718631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.
    Ishengoma DS; Mandara CI; Bakari C; Fola AA; Madebe RA; Seth MD; Francis F; Buguzi CC; Moshi R; Garimo I; Lazaro S; Lusasi A; Aaron S; Chacky F; Mohamed A; Njau RJA; Kitau J; Rasmussen C; Bailey JA; Juliano JJ; Warsame M
    Lancet Infect Dis; 2024 Nov; 24(11):1225-1233. PubMed ID: 39159633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and supersensitive allele detection of Plasmodium falciparum chloroquine resistance via a Pyrococcus furiosus argonaute-triggered dual-signal biosensing platform.
    Chen L; Chen W; Wei H; Lin W; Zhang C; Hu H; Wang C; Chen J; Liang X; Zhu D; Wang J; Lin Z; Wei Y; Li J; Lin M
    Parasit Vectors; 2024 Nov; 17(1):488. PubMed ID: 39582041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.